Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.49B |
| 2 |
Cloudflare
NET
|
+$1.3B |
| 3 |
Roblox
RBLX
|
+$1.1B |
| 4 |
Wayfair
W
|
+$1.05B |
| 5 |
Microsoft
MSFT
|
+$708M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.83B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.24B |
| 3 |
Amazon
AMZN
|
+$1.48B |
| 4 |
Intuitive Surgical
ISRG
|
+$1.39B |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.18% |
| 2 | Healthcare | 9.88% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Communication Services | 9.1% |
| 5 | Financials | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5126
Delcath Systems
DCTH
$588M
| $747K | ﹤0.01% |
59,242
+12,602
| +27% | +$144K |
|
5127
Transmedics
TMDX
$3.06B
| $747K | ﹤0.01% |
22,513
-92,094
| -80% | -$2.55M |
|
5128
Global X SuperIncome Preferred ETF
SPFF
$144M
| $745K | ﹤0.01% |
61,733
+2,433
| +4% | +$29.1K |
|
|
BIOC
5129
DELISTED
Biocept, Inc.
BIOC
| $745K | ﹤0.01% |
5,931
+5,928
| +197,600% | +$802K |
|
|
TPGY
5130
DELISTED
TPG Pace Beneficial Finance Corp.
TPGY
| $744K | ﹤0.01% |
57,837
+23,821
| +70% | +$345K |
|
5131
Ovid Therapeutics
OVID
$524M
| $743K | ﹤0.01% |
190,200
+112,266
| +144% | +$443K |
|
5132
ARKO Corp
ARKO
$526M
| $742K | ﹤0.01% |
80,721
+71,330
| +760% | +$726K |
|
5133
Nature's Sunshine
NATR
$268M
| $742K | ﹤0.01% |
42,740
+38,346
| +873% | +$758K |
|
5134
SIGA Technologies
SIGA
$207M
| $741K | ﹤0.01% |
117,833
+112,992
| +2,334% | +$776K |
|
|
CCVI
5135
DELISTED
Churchill Capital Corp VI
CCVI
| $741K | ﹤0.01% |
+75,106
| New | +$746K |
|
5136
FlexShares Morningstar US Market Factors Tilt Index Fund
TILT
$2.27B
| $740K | ﹤0.01% |
4,346
-1,542
| -26% | -$258K |
|
5137
Traws Pharma
TRAW
$9.32M
| $740K | ﹤0.01% |
4,271
+3,960
| +1,273% | +$896K |
|
|
MBII
5138
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $740K | ﹤0.01% |
446,013
+183,518
| +70% | +$307K |
|
|
BTAQ
5139
DELISTED
Burgundy Technology Acquisition Corporation Class A Ordinary shares
BTAQ
| $737K | ﹤0.01% |
74,821
-40,232
| -35% | -$399K |
|
|
DHF
5140
BNY Mellon High Yield Strategies Fund
DHF
$176M
| $736K | ﹤0.01% |
201,666
+19,382
| +11% | +$61.7K |
|
5141
Identive
INVE
$63.4M
| $734K | ﹤0.01% |
43,136
+37,084
| +613% | +$560K |
|
|
PTE
5142
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $733K | ﹤0.01% |
28,740
+22,493
| +360% | +$591K |
|
|
EVLO
5143
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $732K | ﹤0.01% |
2,661
-740
| -22% | -$187K |
|
5144
Park-Ohio Holdings
PKOH
$711M
| $731K | ﹤0.01% |
22,795
-1,997
| -8% | -$70.3K |
|
5145
Geron
GERN
$956M
| $730K | ﹤0.01% |
518,232
-745,475
| -59% | -$1.08M |
|
|
APR
5146
DELISTED
Apria, Inc. Common Stock
APR
| $729K | ﹤0.01% |
26,028
+25,987
| +63,383% | +$763K |
|
5147
Equity Bancshares
EQBK
$1.07B
| $728K | ﹤0.01% |
23,851
+14,272
| +149% | +$437K |
|
|
INZY
5148
DELISTED
Inozyme Pharma
INZY
| $728K | ﹤0.01% |
42,754
+18,204
| +74% | +$317K |
|
|
LOTZ
5149
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
| $727K | ﹤0.01% |
133,122
-74,285
| -36% | -$468K |
|
|
HMTV
5150
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $727K | ﹤0.01% |
61,655
+5,929
| +11% | +$73.5K |
|
Similar funds
Morgan Stanley's Q2 2021 Portfolio in Review
As of Q2 2021, Morgan Stanley held 8,036 positions worth $758B, up 11% from $681B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley deployed $26.3B of net new capital in Q2 2021, opening 455 new positions and adding to 4,497 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 49,152,168 shares worth $695M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $6.83B trimmed.
- Morgan Stanley's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 49,152,168 shares worth $695M.
- Morgan Stanley added most to Vanguard Total Bond Market in Q2 2021, an estimated $1.49B increase.
- Morgan Stanley's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.83B.
- Morgan Stanley fully exited RealPage, Inc. in Q2 2021, selling an estimated $193M.
- Morgan Stanley's ten largest holdings make up 15% of its $758B portfolio in Q2 2021.
- Morgan Stanley opened 455 new positions and closed 221 in Q2 2021.
- Morgan Stanley's portfolio value rose 11% quarter-over-quarter to $758B.
Based on Morgan Stanley's 13F filing for Q2 2021, filed 16 Aug 2021.